Evidence map›Paper›PMID 37100561›Full record

SynthesisJACC. Cardiovascular interventions2023

Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies.

Nishant Jain, Muhammad A Sheikh, Divyansh Bajaj, Whitney Townsend, Richard Krasuski, Eric Secemsky, Saurav Chatterjee, Victor Moles, Prachi P Agarwal, Jonathan Haft and 6 more

Abstract readSystematic Review
In one paragraph

Synthesis in JACC. Cardiovascular interventions, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Observational
  3. Imaging in chronic thromboembolic pulmonary hypertension: review of the current literature.Diagnostic and interventional radiology (Ankara, Turkey) · 2026
    Review
  4. Article
  5. Management of Balloon Pulmonary Angioplasty Complications: An Ounce of Prevention is a Pound of Cure.Journal of the Society for Cardiovascular Angiography & Interventions · 2026
    Article
  6. Review
  7. Review
  8. Chronic thromboembolic pulmonary disease.The European respiratory journal · 2024
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Nishant JainDepartment of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Muhammad A SheikhDivision of Cardiology, Department of Internal Medicine, Southern Illinois University School of Medicine, Springfield, Illinois, USA.
Divyansh BajajDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Whitney TownsendUniversity of Michigan Taubman Health Sciences Library, Ann Arbor, Michigan, USA.
Richard KrasuskiDivision of Cardiology, Duke University Medical Center, Durham, North Carolina, USA.
Eric SecemskySmith Center for Outcomes Research in Cardiology, Division of Cardiology, Department of Medicine (E.A.S.), Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Saurav ChatterjeeDivision of Cardiovascular Medicine, North Shore-Long Island Jewish Medical Centers, Northwell Health, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York, USA.
Victor MolesDivision of Cardiology (Frankel Cardiovascular Center), Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Prachi P AgarwalDivision of Cardiothoracic Radiology, Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Jonathan HaftDepartment of Cardiac Surgery, University of Michigan, Ann Arbor, Michigan, USA.
Scott H VisovattiDivision of Cardiovascular Medicine, Department of Internal Medicine, The Ohio State University, Columbus, Ohio, USA.
Thomas M CascinoDivision of Cardiology (Frankel Cardiovascular Center), Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Kenneth RosenfieldDivision of Cardiology, Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Brahmajee K NallamothuDivision of Cardiology (Frankel Cardiovascular Center), Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Section of Cardiology, Department of Internal Medicine, Veterans Affairs Medical Center, Ann Arbor, Michigan, USA.
Vallerie V MclaughlinDivision of Cardiology (Frankel Cardiovascular Center), Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.
Vikas AggarwalDivision of Cardiology (Frankel Cardiovascular Center), Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Section of Cardiology, Department of Internal Medicine, Veterans Affairs Medical Center, Ann Arbor, Michigan, USA. Electronic address: aggarwav@med.umich.edu.

Funding

Shared Decision-Making to Improve the Health Status of Patients with Claudication: Developing and Implementing Strategies to Individualize Treatment DecisionsK23HL150290 · NHLBI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI SECEMSKY, ERIC ALEXANDER · 2020 to 2024
$851k
NHLBI NIH HHS K23 HL150290
6 · The paper itself

Abstract

backgroundBalloon pulmonary angioplasty (BPA) was introduced as a treatment modality for patients with inoperable, medically refractory chronic thromboembolic pulmonary hypertension decades ago; however, reports of high rates of pulmonary vascular injury have led to considerable refinement in procedural technique.

objectivesThe authors sought to better understand the evolution of BPA procedure-related complications over time.

methodsThe authors conducted a systematic review of original articles published by pulmonary hypertension centers globally and performed a pooled cohort analysis of procedure-related outcomes with BPA.

resultsThis systematic review identified 26 published articles from 18 countries worldwide from 2013 to 2022. A total of 1,714 patients underwent 7,561 total BPA procedures with an average follow up of 7.3 months. From the first period (2013-2017) to the second period (2018-2022), the cumulative incidence of hemoptysis/vascular injury decreased from 14.1% (474/3,351) to 7.7% (233/3,029) (P < 0.01); lung injury/reperfusion edema decreased from 11.3% (377/3,351) to 1.4% (57/3,943) (P < 0.01); invasive mechanical ventilation decreased from 0.7% (23/3,195) to 0.1% (4/3,062) (P < 0.01); and mortality decreased from 2.0% (13/636) to 0.8% (8/1,071) (P < 0.01).

conclusionsProcedure-related complications with BPA, including hemoptysis/vascular injury, lung injury/reperfusion edema, mechanical ventilation, and death, were less common in the second period (2018-2022), compared with first period (2013-2017), likely from refinement in patient and lesion selection and procedural technique over time.

Indexed as

Angioplasty, BalloonHypertension, PulmonaryLung InjuryPulmonary EdemaPulmonary EmbolismVascular System InjuriesChronic DiseaseEdemaHemoptysisHumansPulmonary ArteryTreatment Outcomeballoon pulmonary angioplastychronic thromboembolic pulmonary hypertensionpulmonary artery angioplasty

Identifiers

PMID37100561
PMCPMC12717829

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.